JPS61501047A - 固定化したリポ−タ−グル−プ類の測定方法 - Google Patents

固定化したリポ−タ−グル−プ類の測定方法

Info

Publication number: JPS61501047A
Authority: JP; Japan
Prior art keywords: component; detection complex; item; complex; detection
Prior art date: 1984-01-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP59501025A

Other languages

English (en)

Japanese (ja)

Inventor

アーノルド，ライル・ジエイ，ジユニア

Original Assignee

モレキュラ−・バイオシステムズ，インコ−ポレイテッド

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-01-27

Filing date

1984-01-27

Publication date

1986-05-22

1984-01-27 Application filed by モレキュラ−・バイオシステムズ，インコ−ポレイテッド filed Critical モレキュラ−・バイオシステムズ，インコ−ポレイテッド

1986-05-22 Publication of JPS61501047A publication Critical patent/JPS61501047A/ja

Status Pending legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims description 125
125000006853 reporter group Chemical group 0.000 title claims description 98
238000001514 detection method Methods 0.000 claims description 215
238000006243 chemical reaction Methods 0.000 claims description 102
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 87
239000000126 substance Substances 0.000 claims description 74
229960002685 biotin Drugs 0.000 claims description 57
239000011616 biotin Substances 0.000 claims description 57
230000003993 interaction Effects 0.000 claims description 53
235000020958 biotin Nutrition 0.000 claims description 47
102000004190 Enzymes Human genes 0.000 claims description 46
108090000790 Enzymes Proteins 0.000 claims description 46
229940088598 enzyme Drugs 0.000 claims description 46
108090001008 Avidin Proteins 0.000 claims description 36
239000011159 matrix material Substances 0.000 claims description 31
BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 claims description 30
238000004020 luminiscence type Methods 0.000 claims description 30
238000009739 binding Methods 0.000 claims description 24
239000003153 chemical reaction reagent Substances 0.000 claims description 23
230000027455 binding Effects 0.000 claims description 22
FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical group OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 claims description 21
108091007433 antigens Proteins 0.000 claims description 20
108090000623 proteins and genes Proteins 0.000 claims description 20
102000004169 proteins and genes Human genes 0.000 claims description 20
239000000427 antigen Substances 0.000 claims description 19
102000036639 antigens Human genes 0.000 claims description 19
238000004132 cross linking Methods 0.000 claims description 19
239000000047 product Substances 0.000 claims description 19
102100031126 6-phosphogluconolactonase Human genes 0.000 claims description 17
108010029731 6-phosphogluconolactonase Proteins 0.000 claims description 17
101710088194 Dehydrogenase Proteins 0.000 claims description 17
108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 claims description 17
239000002523 lectin Substances 0.000 claims description 17
229910052760 oxygen Inorganic materials 0.000 claims description 17
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 16
239000001301 oxygen Substances 0.000 claims description 16
239000003446 ligand Substances 0.000 claims description 15
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 15
DEQPBRIACBATHE-FXQIFTODSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-2-iminopentanoic acid Chemical compound N1C(=O)N[C@@H]2[C@H](CCCC(=N)C(=O)O)SC[C@@H]21 DEQPBRIACBATHE-FXQIFTODSA-N 0.000 claims description 14
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 14
229940088594 vitamin Drugs 0.000 claims description 13
239000011782 vitamin Substances 0.000 claims description 13
AUTOLBMXDDTRRT-JGVFFNPUSA-N (4R,5S)-dethiobiotin Chemical compound C[C@@H]1NC(=O)N[C@@H]1CCCCCC(O)=O AUTOLBMXDDTRRT-JGVFFNPUSA-N 0.000 claims description 12
108090000363 Bacterial Luciferases Proteins 0.000 claims description 12
102000004316 Oxidoreductases Human genes 0.000 claims description 12
108090000854 Oxidoreductases Proteins 0.000 claims description 12
108010090804 Streptavidin Proteins 0.000 claims description 12
150000001299 aldehydes Chemical class 0.000 claims description 12
239000003054 catalyst Substances 0.000 claims description 12
238000004519 manufacturing process Methods 0.000 claims description 12
239000000463 material Substances 0.000 claims description 12
238000012360 testing method Methods 0.000 claims description 12
ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 claims description 11
YTNIXZGTHTVJBW-SCRDCRAPSA-N FMNH2 Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2NC2=C1NC(=O)NC2=O YTNIXZGTHTVJBW-SCRDCRAPSA-N 0.000 claims description 11
108090001090 Lectins Proteins 0.000 claims description 11
102000004856 Lectins Human genes 0.000 claims description 11
230000015572 biosynthetic process Effects 0.000 claims description 11
239000005515 coenzyme Substances 0.000 claims description 11
229930003231 vitamin Natural products 0.000 claims description 11
235000013343 vitamin Nutrition 0.000 claims description 11
235000014633 carbohydrates Nutrition 0.000 claims description 10
150000001720 carbohydrates Chemical class 0.000 claims description 9
239000007795 chemical reaction product Substances 0.000 claims description 9
230000000670 limiting effect Effects 0.000 claims description 9
239000000758 substrate Substances 0.000 claims description 9
150000001412 amines Chemical class 0.000 claims description 8
-1 cofactor Substances 0.000 claims description 8
ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 claims description 8
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 8
UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 claims description 7
108010021809 Alcohol dehydrogenase Proteins 0.000 claims description 7
229910052698 phosphorus Inorganic materials 0.000 claims description 7
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 6
239000002253 acid Substances 0.000 claims description 6
HWYHZTIRURJOHG-UHFFFAOYSA-N luminol Chemical group O=C1NNC(=O)C2=C1C(N)=CC=C2 HWYHZTIRURJOHG-UHFFFAOYSA-N 0.000 claims description 6
239000011574 phosphorus Substances 0.000 claims description 6
WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 claims description 6
150000003573 thiols Chemical class 0.000 claims description 6
102000003960 Ligases Human genes 0.000 claims description 5
108090000364 Ligases Proteins 0.000 claims description 5
230000009830 antibody antigen interaction Effects 0.000 claims description 5
HUDPLKWXRLNSPC-UHFFFAOYSA-N 4-aminophthalhydrazide Chemical compound O=C1NNC(=O)C=2C1=CC(N)=CC=2 HUDPLKWXRLNSPC-UHFFFAOYSA-N 0.000 claims description 4
102000007698 Alcohol dehydrogenase Human genes 0.000 claims description 4
NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 claims description 4
IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 claims description 4
VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 claims description 4
229910019142 PO4 Inorganic materials 0.000 claims description 4
102000013009 Pyruvate Kinase Human genes 0.000 claims description 4
239000003795 chemical substances by application Substances 0.000 claims description 4
150000001875 compounds Chemical class 0.000 claims description 4
239000013067 intermediate product Substances 0.000 claims description 4
229910052751 metal Inorganic materials 0.000 claims description 4
239000002184 metal Substances 0.000 claims description 4
239000010452 phosphate Substances 0.000 claims description 4
238000011002 quantification Methods 0.000 claims description 4
VFEXYZINKMLLAK-UHFFFAOYSA-N 2-(trichloromethyl)oxirane Chemical compound ClC(Cl)(Cl)C1CO1 VFEXYZINKMLLAK-UHFFFAOYSA-N 0.000 claims description 3
XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 claims description 3
ZHBOFZNNPZNWGB-UHFFFAOYSA-N 9,10-bis(phenylethynyl)anthracene Chemical compound C1=CC=CC=C1C#CC(C1=CC=CC=C11)=C(C=CC=C2)C2=C1C#CC1=CC=CC=C1 ZHBOFZNNPZNWGB-UHFFFAOYSA-N 0.000 claims description 3
102000002281 Adenylate kinase Human genes 0.000 claims description 3
108020000543 Adenylate kinase Proteins 0.000 claims description 3
108010062580 Concanavalin A Proteins 0.000 claims description 3
102000004420 Creatine Kinase Human genes 0.000 claims description 3
108010042126 Creatine kinase Proteins 0.000 claims description 3
SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 3
CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 claims description 3
108090000331 Firefly luciferases Proteins 0.000 claims description 3
BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 claims description 3
PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 claims description 3
SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims description 3
102000003855 L-lactate dehydrogenase Human genes 0.000 claims description 3
108700023483 L-lactate dehydrogenases Proteins 0.000 claims description 3
DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 claims description 3
102000010909 Monoamine Oxidase Human genes 0.000 claims description 3
108010062431 Monoamine oxidase Proteins 0.000 claims description 3
108010006232 Neuraminidase Proteins 0.000 claims description 3
102000005348 Neuraminidase Human genes 0.000 claims description 3
102000003992 Peroxidases Human genes 0.000 claims description 3
108020005115 Pyruvate Kinase Proteins 0.000 claims description 3
UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims description 3
WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims description 3
108010061314 alpha-L-Fucosidase Proteins 0.000 claims description 3
102000012086 alpha-L-Fucosidase Human genes 0.000 claims description 3
108010062636 apomyoglobin Proteins 0.000 claims description 3
230000001588 bifunctional effect Effects 0.000 claims description 3
229930182830 galactose Natural products 0.000 claims description 3
239000002502 liposome Substances 0.000 claims description 3
KNJDBYZZKAZQNG-UHFFFAOYSA-N lucigenin Chemical compound [O-][N+]([O-])=O.[O-][N+]([O-])=O.C12=CC=CC=C2[N+](C)=C(C=CC=C2)C2=C1C1=C(C=CC=C2)C2=[N+](C)C2=CC=CC=C12 KNJDBYZZKAZQNG-UHFFFAOYSA-N 0.000 claims description 3
108020004707 nucleic acids Proteins 0.000 claims description 3
150000007523 nucleic acids Chemical class 0.000 claims description 3
102000039446 nucleic acids Human genes 0.000 claims description 3
230000003287 optical effect Effects 0.000 claims description 3
108040007629 peroxidase activity proteins Proteins 0.000 claims description 3
150000002978 peroxides Chemical class 0.000 claims description 3
229940079877 pyrogallol Drugs 0.000 claims description 3
230000004044 response Effects 0.000 claims description 3
YYMBJDOZVAITBP-UHFFFAOYSA-N rubrene Chemical compound C1=CC=CC=C1C(C1=C(C=2C=CC=CC=2)C2=CC=CC=C2C(C=2C=CC=CC=2)=C11)=C(C=CC=C2)C2=C1C1=CC=CC=C1 YYMBJDOZVAITBP-UHFFFAOYSA-N 0.000 claims description 3
230000007306 turnover Effects 0.000 claims description 3
102000002260 Alkaline Phosphatase Human genes 0.000 claims description 2
108020004774 Alkaline Phosphatase Proteins 0.000 claims description 2
108010015776 Glucose oxidase Proteins 0.000 claims description 2
239000004366 Glucose oxidase Substances 0.000 claims description 2
230000004913 activation Effects 0.000 claims description 2
108010005774 beta-Galactosidase Proteins 0.000 claims description 2
108091008324 binding proteins Proteins 0.000 claims description 2
150000001718 carbodiimides Chemical group 0.000 claims description 2
125000001295 dansyl group Chemical group [H]C1=C([H])C(N(C([H])([H])[H])C([H])([H])[H])=C2C([H])=C([H])C([H])=C(C2=C1[H])S(*)(=O)=O 0.000 claims description 2
229940079593 drug Drugs 0.000 claims description 2
239000003814 drug Substances 0.000 claims description 2
229940116332 glucose oxidase Drugs 0.000 claims description 2
235000019420 glucose oxidase Nutrition 0.000 claims description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
229910052700 potassium Inorganic materials 0.000 claims description 2
150000003722 vitamin derivatives Chemical class 0.000 claims 8
XJLXINKUBYWONI-NNYOXOHSSA-O NADP(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-O 0.000 claims 3
125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 3
OURODNXVJUWPMZ-UHFFFAOYSA-N 1,2-diphenylanthracene Chemical compound C1=CC=CC=C1C1=CC=C(C=C2C(C=CC=C2)=C2)C2=C1C1=CC=CC=C1 OURODNXVJUWPMZ-UHFFFAOYSA-N 0.000 claims 2
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 2
102100033220 Xanthine oxidase Human genes 0.000 claims 2
108010093894 Xanthine oxidase Proteins 0.000 claims 2
125000003158 alcohol group Chemical group 0.000 claims 2
239000007822 coupling agent Substances 0.000 claims 2
125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 claims 2
CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 claims 2
150000004032 porphyrins Chemical group 0.000 claims 2
IMDFUULUSORJLH-BTVCFUMJSA-N 3,7-dihydropurine-2,6-dione (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound N1C(=O)NC=2N=CNC2C1=O.O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO IMDFUULUSORJLH-BTVCFUMJSA-N 0.000 claims 1
102100026189 Beta-galactosidase Human genes 0.000 claims 1
YPZRHBJKEMOYQH-UYBVJOGSSA-N FADH2 Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1COP(O)(=O)OP(O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C(NC(=O)NC2=O)=C2NC2=C1C=C(C)C(C)=C2 YPZRHBJKEMOYQH-UYBVJOGSSA-N 0.000 claims 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
102000045595 Phosphoprotein Phosphatases Human genes 0.000 claims 1
108700019535 Phosphoprotein Phosphatases Proteins 0.000 claims 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
108010031852 Pyruvate Synthase Proteins 0.000 claims 1
230000000890 antigenic effect Effects 0.000 claims 1
WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 claims 1
102000023732 binding proteins Human genes 0.000 claims 1
229910052731 fluorine Inorganic materials 0.000 claims 1
239000011737 fluorine Substances 0.000 claims 1
102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 claims 1
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 claims 1
VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims 1
239000012528 membrane Substances 0.000 claims 1
229920000620 organic polymer Polymers 0.000 claims 1
239000011591 potassium Substances 0.000 claims 1
230000006916 protein interaction Effects 0.000 claims 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
230000001568 sexual effect Effects 0.000 claims 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims 1
150000003641 trioses Chemical class 0.000 claims 1
108091009357 vitamin binding proteins Proteins 0.000 claims 1
102000028728 vitamin binding proteins Human genes 0.000 claims 1
239000000243 solution Substances 0.000 description 37
108020004414 DNA Proteins 0.000 description 36
229920001213 Polysorbate 20 Polymers 0.000 description 22
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 22
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 20
239000002953 phosphate buffered saline Substances 0.000 description 18
229920000936 Agarose Polymers 0.000 description 17
108091034117 Oligonucleotide Proteins 0.000 description 16
239000011324 bead Substances 0.000 description 15
230000000694 effects Effects 0.000 description 15
238000005259 measurement Methods 0.000 description 13
238000005406 washing Methods 0.000 description 12
230000003197 catalytic effect Effects 0.000 description 11
150000002148 esters Chemical class 0.000 description 10
239000000020 Nitrocellulose Substances 0.000 description 9
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
229920001220 nitrocellulos Polymers 0.000 description 9
230000002285 radioactive effect Effects 0.000 description 9
230000035945 sensitivity Effects 0.000 description 9
241000700721 Hepatitis B virus Species 0.000 description 8
230000002255 enzymatic effect Effects 0.000 description 7
239000000203 mixture Substances 0.000 description 7
238000011160 research Methods 0.000 description 7
239000000523 sample Substances 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
230000001580 bacterial effect Effects 0.000 description 6
238000005415 bioluminescence Methods 0.000 description 6
230000029918 bioluminescence Effects 0.000 description 6
238000007413 biotinylation Methods 0.000 description 6
230000006287 biotinylation Effects 0.000 description 6
239000000872 buffer Substances 0.000 description 6
238000002372 labelling Methods 0.000 description 6
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
241000700584 Simplexvirus Species 0.000 description 5
230000008901 benefit Effects 0.000 description 5
238000000504 luminescence detection Methods 0.000 description 5
238000000691 measurement method Methods 0.000 description 5
235000020004 porter Nutrition 0.000 description 5
150000003839 salts Chemical class 0.000 description 5
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 4
239000007983 Tris buffer Substances 0.000 description 4
XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 4
125000004429 atom Chemical group 0.000 description 4
230000000295 complement effect Effects 0.000 description 4
230000000875 corresponding effect Effects 0.000 description 4
230000001419 dependent effect Effects 0.000 description 4
HFJRKMMYBMWEAD-UHFFFAOYSA-N dodecanal Chemical compound CCCCCCCCCCCC=O HFJRKMMYBMWEAD-UHFFFAOYSA-N 0.000 description 4
229930195733 hydrocarbon Natural products 0.000 description 4
239000007788 liquid Substances 0.000 description 4
229920000136 polysorbate Polymers 0.000 description 4
230000002829 reductive effect Effects 0.000 description 4
238000011896 sensitive detection Methods 0.000 description 4
239000000725 suspension Substances 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 3
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
108010088751 Albumins Proteins 0.000 description 3
102000009027 Albumins Human genes 0.000 description 3
108091003079 Bovine Serum Albumin Proteins 0.000 description 3
239000004215 Carbon black (E152) Substances 0.000 description 3
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
230000009471 action Effects 0.000 description 3
150000001336 alkenes Chemical class 0.000 description 3
229940098773 bovine serum albumin Drugs 0.000 description 3
238000012875 competitive assay Methods 0.000 description 3
230000021615 conjugation Effects 0.000 description 3
MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 description 3
238000000502 dialysis Methods 0.000 description 3
238000009396 hybridization Methods 0.000 description 3
150000002430 hydrocarbons Chemical class 0.000 description 3
229910052739 hydrogen Inorganic materials 0.000 description 3
239000001257 hydrogen Substances 0.000 description 3
125000004435 hydrogen atom Chemical class [H]* 0.000 description 3
238000011534 incubation Methods 0.000 description 3
239000000543 intermediate Substances 0.000 description 3
229910001629 magnesium chloride Inorganic materials 0.000 description 3
239000002245 particle Substances 0.000 description 3
239000013612 plasmid Substances 0.000 description 3
229920003023 plastic Polymers 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
230000005855 radiation Effects 0.000 description 3
238000000926 separation method Methods 0.000 description 3
239000002002 slurry Substances 0.000 description 3
235000017557 sodium bicarbonate Nutrition 0.000 description 3
229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
229910052717 sulfur Inorganic materials 0.000 description 3
HSHNITRMYYLLCV-UHFFFAOYSA-N 4-methylumbelliferone Chemical compound C1=C(O)C=CC2=C1OC(=O)C=C2C HSHNITRMYYLLCV-UHFFFAOYSA-N 0.000 description 2
108020005199 Dehydrogenases Proteins 0.000 description 2
AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 2
241000192130 Leuconostoc mesenteroides Species 0.000 description 2
101710160107 Outer membrane protein A Proteins 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical group O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
238000009825 accumulation Methods 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
150000001408 amides Chemical class 0.000 description 2
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
229910052921 ammonium sulfate Inorganic materials 0.000 description 2
235000011130 ammonium sulphate Nutrition 0.000 description 2
230000003321 amplification Effects 0.000 description 2
239000012491 analyte Substances 0.000 description 2
238000003556 assay Methods 0.000 description 2
108010063086 avidin-agarose Proteins 0.000 description 2
238000003390 bioluminescence detection Methods 0.000 description 2
210000004027 cell Anatomy 0.000 description 2
229920002678 cellulose Polymers 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
238000000576 coating method Methods 0.000 description 2
239000002131 composite material Substances 0.000 description 2
150000008049 diazo compounds Chemical class 0.000 description 2
150000002170 ethers Chemical class 0.000 description 2
239000012847 fine chemical Substances 0.000 description 2
239000012634 fragment Substances 0.000 description 2
125000000524 functional group Chemical group 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
238000002796 luminescence method Methods 0.000 description 2
BGEHHAVMRVXCGR-UHFFFAOYSA-N methylundecylketone Natural products CCCCCCCCCCCCC=O BGEHHAVMRVXCGR-UHFFFAOYSA-N 0.000 description 2
238000012544 monitoring process Methods 0.000 description 2
230000009871 nonspecific binding Effects 0.000 description 2
238000003199 nucleic acid amplification method Methods 0.000 description 2
239000008057 potassium phosphate buffer Substances 0.000 description 2
239000000941 radioactive substance Substances 0.000 description 2
239000000376 reactant Substances 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
239000011734 sodium Substances 0.000 description 2
239000002904 solvent Substances 0.000 description 2
230000009870 specific binding Effects 0.000 description 2
239000011269 tar Substances 0.000 description 2
150000003568 thioethers Chemical class 0.000 description 2
FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
210000001541 thymus gland Anatomy 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
238000012546 transfer Methods 0.000 description 2
238000013519 translation Methods 0.000 description 2
RNIPJYFZGXJSDD-UHFFFAOYSA-N 2,4,5-triphenyl-1h-imidazole Chemical compound C1=CC=CC=C1C1=NC(C=2C=CC=CC=2)=C(C=2C=CC=CC=2)N1 RNIPJYFZGXJSDD-UHFFFAOYSA-N 0.000 description 1
FKNOXOCHYZMIEM-UHFFFAOYSA-N 2-(pyridin-2-yldisulfanyl)propanoic acid Chemical compound OC(=O)C(C)SSC1=CC=CC=N1 FKNOXOCHYZMIEM-UHFFFAOYSA-N 0.000 description 1
AYXZIZMZXAORLO-UFLZEWODSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid;1-hydroxypyrrolidine-2,5-dione Chemical compound ON1C(=O)CCC1=O.N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 AYXZIZMZXAORLO-UFLZEWODSA-N 0.000 description 1
CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical group N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
241000023308 Acca Species 0.000 description 1
239000004382 Amylase Substances 0.000 description 1
102000013142 Amylases Human genes 0.000 description 1
108010065511 Amylases Proteins 0.000 description 1
229920000945 Amylopectin Polymers 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
241000283707 Capra Species 0.000 description 1
KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
235000021513 Cinchona Nutrition 0.000 description 1
241000157855 Cinchona Species 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
102000018832 Cytochromes Human genes 0.000 description 1
108010052832 Cytochromes Proteins 0.000 description 1
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
108020003215 DNA Probes Proteins 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
241001669680 Dormitator maculatus Species 0.000 description 1
241000195955 Equisetum hyemale Species 0.000 description 1
229920001917 Ficoll Polymers 0.000 description 1
101001056976 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) Catalase-peroxidase Proteins 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
LFVLUOAHQIVABZ-UHFFFAOYSA-N Iodofenphos Chemical compound COP(=S)(OC)OC1=CC(Cl)=C(I)C=C1Cl LFVLUOAHQIVABZ-UHFFFAOYSA-N 0.000 description 1
235000019687 Lamb Nutrition 0.000 description 1
241000254158 Lampyridae Species 0.000 description 1
102000004895 Lipoproteins Human genes 0.000 description 1
108090001030 Lipoproteins Proteins 0.000 description 1
108060001084 Luciferase Proteins 0.000 description 1
239000005089 Luciferase Substances 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
102000013460 Malate Dehydrogenase Human genes 0.000 description 1
108010026217 Malate Dehydrogenase Proteins 0.000 description 1
PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
101150089387 NAD10 gene Proteins 0.000 description 1
MUBZPKHOEPUJKR-UHFFFAOYSA-L Oxalate Chemical compound [O-]C(=O)C([O-])=O MUBZPKHOEPUJKR-UHFFFAOYSA-L 0.000 description 1
241001602688 Pama Species 0.000 description 1
241000287462 Phalacrocorax carbo Species 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
108091007187 Reductases Proteins 0.000 description 1
229920005654 Sephadex Polymers 0.000 description 1
239000012507 Sephadex™ Substances 0.000 description 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
102000004357 Transferases Human genes 0.000 description 1
108090000992 Transferases Proteins 0.000 description 1
YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
241000607618 Vibrio harveyi Species 0.000 description 1
235000010724 Wisteria floribunda Nutrition 0.000 description 1
POOGXHSMLJDKRF-SOOFDHNKSA-N [(3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-2-phosphonooxyoxolan-3-yl] dihydrogen phosphate Chemical compound OC[C@H]1OC(OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1O POOGXHSMLJDKRF-SOOFDHNKSA-N 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
239000012190 activator Substances 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
125000001931 aliphatic group Chemical group 0.000 description 1
235000019418 amylase Nutrition 0.000 description 1
238000000137 annealing Methods 0.000 description 1
230000003602 anti-herpes Effects 0.000 description 1
229910052785 arsenic Inorganic materials 0.000 description 1
RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
235000021167 banquet Nutrition 0.000 description 1
238000003287 bathing Methods 0.000 description 1
102000005936 beta-Galactosidase Human genes 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
239000012888 bovine serum Substances 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
244000309466 calf Species 0.000 description 1
150000007942 carboxylates Chemical class 0.000 description 1
239000000969 carrier Substances 0.000 description 1
238000006555 catalytic reaction Methods 0.000 description 1
230000008859 change Effects 0.000 description 1
239000013522 chelant Substances 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
125000003636 chemical group Chemical group 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
239000011248 coating agent Substances 0.000 description 1
238000004737 colorimetric analysis Methods 0.000 description 1
230000009137 competitive binding Effects 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
239000007799 cork Substances 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
239000012954 diazonium Substances 0.000 description 1
150000001989 diazonium salts Chemical class 0.000 description 1
230000029087 digestion Effects 0.000 description 1
238000007865 diluting Methods 0.000 description 1
229960001760 dimethyl sulfoxide Drugs 0.000 description 1
150000002009 diols Chemical group 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
230000003670 easy-to-clean Effects 0.000 description 1
235000013399 edible fruits Nutrition 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
150000002085 enols Chemical class 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
238000012869 ethanol precipitation Methods 0.000 description 1
230000005284 excitation Effects 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
230000002538 fungal effect Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
231100001261 hazardous Toxicity 0.000 description 1
208000002672 hepatitis B Diseases 0.000 description 1
229940094991 herring sperm dna Drugs 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
230000000155 isotopic effect Effects 0.000 description 1
230000004130 lipolysis Effects 0.000 description 1
125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
150000002730 mercury Chemical class 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
MJFJKKXQDNNUJF-UHFFFAOYSA-N metixene Chemical compound C1N(C)CCCC1CC1C2=CC=CC=C2SC2=CC=CC=C21 MJFJKKXQDNNUJF-UHFFFAOYSA-N 0.000 description 1
108010029942 microperoxidase Proteins 0.000 description 1
238000002156 mixing Methods 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
150000002912 oxalic acid derivatives Chemical class 0.000 description 1
150000003901 oxalic acid esters Chemical class 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
230000033116 oxidation-reduction process Effects 0.000 description 1
150000002924 oxiranes Chemical class 0.000 description 1
238000012856 packing Methods 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
230000008775 paternal effect Effects 0.000 description 1
244000052769 pathogen Species 0.000 description 1
KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
150000004965 peroxy acids Chemical class 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
239000006187 pill Substances 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
150000003141 primary amines Chemical class 0.000 description 1
230000008569 process Effects 0.000 description 1
229960003581 pyridoxal Drugs 0.000 description 1
235000008164 pyridoxal Nutrition 0.000 description 1
239000011674 pyridoxal Substances 0.000 description 1
229940076788 pyruvate Drugs 0.000 description 1
229940107700 pyruvic acid Drugs 0.000 description 1
230000005258 radioactive decay Effects 0.000 description 1
238000000163 radioactive labelling Methods 0.000 description 1
239000002994 raw material Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
238000012552 review Methods 0.000 description 1
230000007017 scission Effects 0.000 description 1
210000001625 seminal vesicle Anatomy 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
239000012064 sodium phosphate buffer Substances 0.000 description 1
239000008279 sol Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000004611 spectroscopical analysis Methods 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
238000010186 staining Methods 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
125000001424 substituent group Chemical group 0.000 description 1
150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
238000001308 synthesis method Methods 0.000 description 1
GEVPIWPYWJZSPR-UHFFFAOYSA-N tcpo Chemical compound ClC1=CC(Cl)=CC(Cl)=C1OC(=O)C(=O)OC1=C(Cl)C=C(Cl)C=C1Cl GEVPIWPYWJZSPR-UHFFFAOYSA-N 0.000 description 1
150000007970 thio esters Chemical class 0.000 description 1
150000003585 thioureas Chemical class 0.000 description 1
230000001960 triggered effect Effects 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
229910052722 tritium Inorganic materials 0.000 description 1
ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
201000010653 vesiculitis Diseases 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

JP59501025A 1984-01-27 1984-01-27 固定化したリポ−タ−グル−プ類の測定方法 Pending JPS61501047A (ja)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US1984/000138 WO1985003356A1 (fr)	1984-01-27	1984-01-27	Analyse pour la detection de groupes rapporteurs immobilises

Publications (1)

Publication Number	Publication Date
JPS61501047A true JPS61501047A (ja)	1986-05-22

Family

ID=22182033

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP59501025A Pending JPS61501047A (ja)	1984-01-27	1984-01-27	固定化したリポ−タ−グル−プ類の測定方法

Country Status (6)

Country	Link
EP (1)	EP0170652A4 (fr)
JP (1)	JPS61501047A (fr)
AU (1)	AU582341B2 (fr)
DK (1)	DK436785D0 (fr)
NO (1)	NO853790L (fr)
WO (1)	WO1985003356A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2025211296A1 (fr) *	2024-04-05	2025-10-09	国立大学法人京都大学	Enzyme de type transfert d'électrons direct et utilisation associée

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU3844485A (en) *	1984-02-09	1985-08-15	Enzo Biochem Inc.	Heterologous detection of cabeled dna
FR2602592B1 (fr) *	1986-08-06	1989-06-30	Alain Baret	Utilisation du systeme enzymatique xanthine-oxydase en immuno-analyse, procedes de dosage correspondants et coffrets de reactifs necessaires pour la mise en oeuvre de ces procedes.
GB8628108D0 (en) *	1986-11-25	1986-12-31	London Biotechnology Ltd	Riboflavin-linked assay
WO1989011544A1 (fr) *	1988-05-21	1989-11-30	London Biotechnology Limited	Procedures et materiaux d'analyse a liaison par riboflavine
US5888728A (en)	1988-10-17	1999-03-30	Molecular Devices Corporation	Hapten derivatized capture membrane and diagnostic assays using such membrane
WO2001081618A1 (fr) *	2000-04-26	2001-11-01	Kikkoman Corporation	Procede de mesure de luminescence biologique

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4383031A (en) *	1975-04-28	1983-05-10	Miles Laboratories, Inc.	Homogeneous chemiluminescent specific binding assay
SE404553B (sv) *	1977-03-04	1978-10-09	Pharmacia Diagnostics Ab	Sett vid bestemningsmetoder involverande biospecifika affinitetsreaktioner
JPS5510590A (en) *	1978-05-04	1980-01-25	Wellcome Found	Enzyme immunity quantity analysis
US4228237A (en) *	1978-09-21	1980-10-14	Calbiochem-Behring Corp.	Methods for the detection and determination of ligands
US4334017A (en) *	1979-04-16	1982-06-08	Massachusetts Institute Of Technology	Method for detecting cancer in mammalian tissue
US4358535A (en) *	1980-12-08	1982-11-09	Board Of Regents Of The University Of Washington	Specific DNA probes in diagnostic microbiology
CA1219824A (fr) *	1981-04-17	1987-03-31	David C. Ward	Nucleotides modifies, leur preparation et leur emploi
CA1203164A (fr) *	1982-03-09	1986-04-15	Thomas J. Mckearn	Conjugats d'anticorps
DK188184A (da) *	1983-04-20	1984-10-21	Enzo Biochem Inc	Fremgangsmaade til dannelse af et kompleks af biologisk aktive eller funktionelle forbindelser og anvendelse af forbindelserne
JPS607362A (ja) *	1983-06-27	1985-01-16	Fujirebio Inc	酵素を用いた抗原決定基具有物質の測定法
US4737454A (en) *	1983-07-14	1988-04-12	Molecular Diagnostics, Inc.	Fast photochemical method of labelling nucleic acids for detection purposes in hybridization assays
US4582810A (en) *	1983-09-30	1986-04-15	Becton, Dickinson And Company	Immuno-agglutination particle suspensions

1984
- 1984-01-27 EP EP19840901033 patent/EP0170652A4/fr not_active Withdrawn
- 1984-01-27 WO PCT/US1984/000138 patent/WO1985003356A1/fr not_active Ceased
- 1984-01-27 JP JP59501025A patent/JPS61501047A/ja active Pending
- 1984-01-27 AU AU25770/84A patent/AU582341B2/en not_active Ceased
1985
- 1985-09-26 DK DK436785A patent/DK436785D0/da not_active Application Discontinuation
- 1985-09-26 NO NO853790A patent/NO853790L/no unknown

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2025211296A1 (fr) *	2024-04-05	2025-10-09	国立大学法人京都大学	Enzyme de type transfert d'électrons direct et utilisation associée
JPWO2025211296A1 (fr) *	2024-04-05	2025-10-09

Also Published As

Publication number	Publication date
EP0170652A4 (fr)	1988-08-23
AU582341B2 (en)	1989-03-23
DK436785A (da)	1985-09-26
EP0170652A1 (fr)	1986-02-12
WO1985003356A1 (fr)	1985-08-01
NO853790L (no)	1985-09-26
DK436785D0 (da)	1985-09-26
AU2577084A (en)	1985-08-09

Publication	Publication Date	Title
JP2651060B2 (ja)	1997-09-10	同時較正不均質イムノアツセイ用装置
JPS5942454A (ja)	1984-03-09	液体中のハプテン又は抗原を分析するための均一系免疫分析方法及び試薬
US5223393A (en)	1993-06-29	Detection of analytes having binding sites for at least two binding moieties
JPS6188155A (ja)	1986-05-06	フイコビリタンパク質による螢光エネルギ−転位
JPH02180893A (ja)	1990-07-13	１，２−ジオキセタン化合物及びそれを用いた発光方法
JPH09510289A (ja)	1997-10-14	イムノアッセイで使用するための干渉除去剤
CA1166133A (fr)	1984-04-24	Systeme de substrat pour l'amplification de la chemoluminescence en immunochimie
JPH0648996B2 (ja)	1994-06-29	増幅発光分析
US5672475A (en)	1997-09-30	Mixed luminescent conjugate test
US5401636A (en)	1995-03-28	Enhanced sensitivity agglutination assays multivalent ligands
JPS61501047A (ja)	1986-05-22	固定化したリポ−タ−グル−プ類の測定方法
JP3989537B2 (ja)	2007-10-10	１０，１０’−置換−９，９’−ビアクリジン発光分子誘導体及びシグナル溶液の調製
JPS59178362A (ja)	1984-10-09	被検体の検知法
WO1996021154A1 (fr)	1996-07-11	Chimioluminescence electrogeneree par des particules a luminescence accrue
JP2004514460A (ja)	2004-05-20	ルシフェラーゼ生物発光に関する光活性型インビトロアッセイ法
US6159699A (en)	2000-12-12	Enzyme linked chemiluminescent assay
JP4455688B2 (ja)	2010-04-21	分析物遊離段階を可能にするアッセイ用表面
CA1255213A (fr)	1989-06-06	Methode de detection des groupements "reporter"
JPH0560059B2 (fr)	1993-09-01
CA1304291C (fr)	1992-06-30	Transformation catalytique par un intermediaire de reaction modifie, utilisee dans un immuno-essai enzymatique
Luider et al.	1990	Thermochemiluminescence immunoassay for hCG
JPH0454455A (ja)	1992-02-21	多座配位蛍光キレートで標識した生物物質
WO1994023301A1 (fr)	1994-10-13	Methode diagnostique de dosage de renine/angiotensine i
JPS58500084A (ja)	1983-01-13	免疫化学のための化学ルミネセンス増巾基質システム
JPH10239314A (ja)	1998-09-11	結合分析の高感度化方法